An Epidemiological Cohort Study of Acute Coronary Syndromes in The Greek Population. The PHAETHON Study

N/ACompletedNCT02420808

Hellenic Cardiovascular Research Society800 enrolled

Overview

A nationwide registry of patients with acute coronary disease to evaluate epidemiological patient characteristics, medical management, implementation of invasive strategy, patient outcome and impact on quality of life in Greece.

Study Type

OBSERVATIONAL

Enrollment

800

Conditions

Coronary Artery Disease

Eligibility

Sex: ALLMin age: 25 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Informed Consent * \> 25 years * Admission in hospital within 24 hours from beginning of symptoms of transfer from antother hospital within 24 hours from beginning of symptoms. * Acute Coronary Syndrom Exclusion Criteria: \-

Locations (1)

General Hospital of Chalkida

Chalcis, Greece

Outcomes

Primary Outcomes

Evaluation of patients with Acute Coronary Syndromes.

Assessment of the epidemiological characteristics of patients who were hospitalized with a diagnosis of ACS. Evaluation of the therapeutic strategy and its outcome.

Time frame: 6 months

Secondary Outcomes

Estimation of the percentage of patients.

Estimation of the percentage of patients who were hospitalized with STEMI, NSTEMI and unstable angina.

Time frame: Baseline

Description of the methods of patients' evacuation.

Description of the methods of patients' evacuation from the scene of the incident to the receiving hospital where was processed the treatment for ACS.

Time frame: Baseline

Estimation of the interval until the arrival in the hospital.

Estimation of the duration from the onset of pain until the arrival in the receiving hospital at various locations.

Time frame: Baseline

Evaluation of the blood test analysis during hospitalization.

Evaluation of hematological, biochemical parameters and myocardial necrosis markers during hospitalization.

Time frame: Baseline

Description of the administered medication.

Description of the pharmaceutical treatment administered during hospitalization and monitoring period.

Time frame: Baseline - 6 months

Evaluation of the male patients with erectile dysfunction.

Estimation of the percentage of the male patients with erectile dysfuction based to a predesigned questionnaire and investigation of the possible association with the treatment's outcome.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.